Verici Dx Ordinary Shares (LSE:VRCI)

UK company
add to virtual portfolio
trade
This share can be held in
Trading AccountISAJISASIPP

Share Price Chart

- Chart currently unavailable -

Market Info - VRCI

  • Market Open Price0.00
  • Previous Close0.00
  • Volume-
  • 52w Low/High-
  • Last Trade Price0.00
  • Bid/Ask Price0.00

Company Info - VRCI

  • Market Cap£124.030m
  • SymbolLSE:VRCI
  • IndustryHealthcare
  • SectorDiagnostics & Research
  • Currency
  • ISINGB00BM8HZD43

Company Profile

Verici Dx PLC is an immuno-diagnostics development company. The company is focused on developing diagnostics technologies which will help understand the outcomes of an organ transplant surgery. There are two products for clinical validation and commercialisation: Clarava, which is a pre-transplant prognosis for the risk of early acute rejection ("EAR"); and Tuteva, a post-transplant diagnostic focused upon acute cellular rejection including sub-clinical rejection not being diagnosed through the current standard of care of rising serum creatine levels.

Latest VRCI news

Currently there for this company. Visit our news hub for other news .

VRCI Regulatory news

Currently there for this company. Visit our news hub for other news .